Cargando…
Efficacy of Typhoid Conjugate Vaccine in Nepal: An Interim Analysis of a Participant-and Observer-Blinded Randomized Phase III Trial
BACKGROUND: Salmonella Typhi is a major cause of fever in children in low- and middle-income countries. The recently WHO prequalified typhoid conjugate vaccine (TCV) was shown to be efficacious in a human challenge model but no efficacy trials in endemic populations have been completed. METHODS: In...
Autores principales: | Shakya, Mila, Colin-Jones, Rachel, Theiss-Nyland, Katherine, Voysey, Merryn, Pant, Dikshya, Smith, Nicola, Liu, Xinxue, Tonks, Susan, Mazur, Olga, Farooq, Yama G., Clarke, Jenny, Hill, Jennifer, Adhikari, Anup, Dongol, Sabina, Karkey, Abhilasha, Bajracharya, Binod, Kelly, Sarah, Gurung, Meeru, Baker, Stephen, Neuzil, Kathleen M., Shrestha, Shrijana, Basnyat, Buddha, Pollard, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Massachusetts Medical Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785806/ https://www.ncbi.nlm.nih.gov/pubmed/31800986 http://dx.doi.org/10.1056/NEJMoa1905047 |
Ejemplares similares
-
Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal
por: Colin-Jones, Rachel, et al.
Publicado: (2019) -
Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial
por: Theiss-Nyland, Katherine, et al.
Publicado: (2019) -
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial
por: Shakya, Mila, et al.
Publicado: (2021) -
Under-detection of blood culture-positive enteric fever cases: The impact of missing data and methods for adjusting incidence estimates
por: Voysey, Merryn, et al.
Publicado: (2020) -
Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt
por: Dahal, Ashata, et al.
Publicado: (2022)